Senators Introduce MCO Bill

11 May 1997

- Two Republican Senators have introduced a bill allowing managed careprogram enrollees to choose their own doctors, and removing limits on doctors discussing all treatment options with them.

Plans would be liable for wrongful death or personal injuries, allowing patients covered by the Employee Retirement Income Security Act to sue for malpractice; ERISA exempts many large company-sponsored plans from state insurance laws and regulations. The bill would also require plans to publish and give each patient a list of what they cover, company costs and profits, and details of spending on marketing and other non-health costs. Patients would not need prior approval before going to an emergency room.

The introduction of the bill calling for the new consumer protections on managed care plans is seen as making it more likely that Congress will take action on this issue during the current session.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight